Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management

BACKGROUND: Drug-induced colitis is a known complication of therapies that alter the immune balance, damage the intestinal barrier or disturb intestinal microbiota. Immune checkpoint inhibitors (ICI) directed against cancer cells may result in activated T lymphocyte-induced immune-related adverse ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Shivaji, Uday N., Jeffery, Louisa, Gui, Xianyong, Smith, Samuel C. L., Ahmad, Omer F., Akbar, Ayesha, Ghosh, Subrata, Iacucci, Marietta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831976/
https://www.ncbi.nlm.nih.gov/pubmed/31723355
http://dx.doi.org/10.1177/1756284819884196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831976/
https://www.ncbi.nlm.nih.gov/pubmed/31723355
http://dx.doi.org/10.1177/1756284819884196

Ejemplares similares